Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders
1. Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a lower risk of developing new substance use disorders. 2. These ...
1. Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a lower risk of developing new substance use disorders. 2. These ...
1. In this cohort study, higher maternal prenatal body mass index was associated with worse neurocognitive development in offspring. 2. ...
1. Behavioral health integration has had positive effects on a wide variety of practices, but physicians commonly reported frustration with ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.